Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03873649 · ClinicalTrials.gov registry record

Immune Response in Hypersensitivity Pneumonitis

A clinical trial, sponsored by Nabeel Hamzeh.

Completed
Registry status
21
Enrollment target

NCT03873649 is a clinical trial that has completed, run by Nabeel Hamzeh. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03873649 has completed, sponsored by Nabeel Hamzeh.

COMPLETED
Registry status
21 participants
Enrollment target

Study Summary

Hypersensitivity pneumonitis (HP) is an inflammatory lung disease that is caused by exposure of susceptible individuals to organic materials in the environment. It is also known by various names depending on the exposure and some of these names include farmer's lung, pigeon breeder's lung, hot tub lung to name a few. HP can cause lung scarring that impairs breathing and oxygenation. Early detection and avoidance of triggers can stop and reverse the disease but a significant number of patients continue to have active disease requiring treatment in spite of avoiding the trigger. The current choice of therapies is based on clinical experience and not on rigorous clinical trials. Not fully understanding the type of inflammation that is seen in HP and the cells involved in this inflammatory response limits health care providers' ability to choose drugs to study in HP that can stop the inflammation and limit scar formation. The goal of the investigators' study is to better understand the type of cells that are involved in the inflammatory response in the lungs of HP patients and what drives these cells to be active. By better understanding the type of cells and what drives them, health care providers can begin to choose and study drugs that can limit the inflammation and subsequent scarring. The investigators' will recruit HP patients and with their consent perform a scope of the lungs (bronchoscopy) with a limited lung wash to get the inflamed cells out of the lungs to further study them in the lab. The investigators' study will provide us with preliminary results to guide us in performing a more detailed study in the future to better understand the disease.

Interventions

  • OTHER Bronchoscopy with lavage

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2018-11-29
Est. Completion 2022-03-30

Sponsor

Nabeel Hamzeh

2 total trials

What the Registry Record Tells You About NCT03873649

The ClinicalTrials.gov registry entry for NCT03873649 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nabeel Hamzeh, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Bronchoscopy with lavage is the first listed.

NCT03873649 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03873649 about?

NCT03873649 is a clinical study titled "Immune Response in Hypersensitivity Pneumonitis". Hypersensitivity pneumonitis (HP) is an inflammatory lung disease that is caused by exposure of susceptible individuals to organic materials in the environment. It is also known by various names depending on the exposure and some of these names include farmer's lung, pigeon breeder's lung, hot tub l...

What is the current status of trial NCT03873649?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2018-11-29. Estimated completion is 2022-03-30.

What interventions are being tested in trial NCT03873649?

The interventions under investigation include: Bronchoscopy with lavage (OTHER).

Who is sponsoring clinical trial NCT03873649?

This trial is sponsored by Nabeel Hamzeh, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.